Currently, there are 45.51M common shares owned by the public and among those 42.97M shares have been available to trade.
The company’s stock has a 5-day price change of -6.42% and -38.53% over the past three months. AXGN shares are trading -32.83% year to date (YTD), with the 12-month market performance up to 81.77% higher. It has a 12-month low price of $6.02 and touched a high of $21.00 over the same period. AXGN has an average intraday trading volume of 625.34K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -18.15%, -29.08%, and -27.13% respectively.
Institutional ownership of Axogen Inc (NASDAQ: AXGN) shares accounts for 86.22% of the company’s 45.51M shares outstanding.
It has a market capitalization of $504.17M and a beta (3y monthly) value of 1.10. The earnings-per-share (ttm) stands at -$0.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.15% over the week and 6.77% over the month.
Earnings per share for the fiscal year are expected to increase by 60.71%, and 127.35% over the next financial year. EPS should grow at an annualized rate of 86.26% over the next five years, compared to 21.24% over the past 5-year period.
Looking at the support for the AXGN, a number of firms have released research notes about the stock. Lake Street stated their Buy rating for the stock in a research note on March 17, 2025, with the firm’s price target at $30. Raymond James coverage for the Axogen Inc (AXGN) stock in a research note released on July 01, 2024 offered a Outperform rating with a price target of $13. Jefferies was of a view on November 11, 2022 that the stock is Buy, while Canaccord Genuity gave the stock Buy rating on May 09, 2022, issuing a price target of $10- $15. Cantor Fitzgerald on their part issued Overweight rating on March 11, 2022.
